Evidence map›Paper›PMID 36052146›Full record

ArticleFrontiers in pharmacology2022

Effect of

Neelam Gul Qazi, Arif-Ullah Khan, Sumra Wajid Abbasi, Imran Malik, Komal Naeem

RetractedOpen access · goldAbstract readRetracted Publication
In one paragraph

Article in Frontiers in pharmacology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It has been retracted, and should not be counted. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
2.9field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Food science & nutrition · 2025
    Review
  3. Article
  4. Synergistic curative effects ofFrontiers in plant science · 2025
    Article
  5. Pharmacological investigations of newly synthesized oxazolones and imidazolones as COX-2 inhibitors.Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society · 2024
    Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Pharmacological Basis ofMolecules (Basel, Switzerland) · 2022
    Article
  11. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 2 countries.

Neelam Gul QaziRiphah Institute of Pharmaceutical Sciences, Riphah International University, Islamabad, Pakistan.
Arif-Ullah KhanRiphah Institute of Pharmaceutical Sciences, Riphah International University, Islamabad, Pakistan.
Sumra Wajid AbbasiNums Department of Biological Sciences, National University of Medical Sciences Rawalpindi, Rawalpindi, Pakistan.
Imran MalikRiphah Institute of Pharmaceutical Sciences, Riphah International University, Islamabad, Pakistan.
Komal NaeemUniversity of Northern British Columbia, Prince George, BC, Canada.
Riphah International University · PKNational University of Medical Sciences · PKUniversity of Northern British Columbia · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This present study aims to delineate

Indexed as

anti-inflammatoryanti-oxidantanti-ulcercalcium channelH/K+-ATPaseRumex dentatus

Identifiers

PMID36052146
PMCPMC9424734
OpenAlexW4292183259

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.